Gabelli Funds’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,300
Closed -$12K 1464
2022
Q1
$12K Buy
1,300
+133
+11% +$2.02K ﹤0.01% 1371
2021
Q4
$25K Sell
1,167
-9,658
-89% -$258K ﹤0.01% 1371
2021
Q3
$354K Sell
10,825
-933
-8% -$34.2K ﹤0.01% 1137
2021
Q2
$490K Sell
11,758
-134
-1% -$6.86K ﹤0.01% 1056
2021
Q1
$778K Sell
11,892
-724
-6% -$50.5K 0.01% 949
2020
Q4
$829K Sell
12,616
-3,303
-21% -$215K 0.01% 912
2020
Q3
$864K Buy
15,919
+4,555
+40% +$348K 0.01% 850
2020
Q2
$1.08M Buy
11,364
+1,016
+10% +$75.7K 0.01% 789
2020
Q1
$531K Buy
10,348
+6,348
+159% +$663K ﹤0.01% 872
2019
Q4
$329K Sell
4,000
-1,500
-27% -$105K ﹤0.01% 982
2019
Q3
$470K Hold
5,500
﹤0.01% 967
2019
Q2
$701K Sell
5,500
-1,167
-18% -$168K ﹤0.01% 940
2019
Q1
$1.2M Hold
6,667
0.01% 843
2018
Q4
$740K Hold
6,667
0.01% 916
2018
Q3
$900K Hold
6,667
0.01% 928
2018
Q2
$920K Hold
6,667
0.01% 919
2018
Q1
$920K Hold
6,667
0.01% 923
2017
Q4
$820K Hold
6,667
﹤0.01% 935
2017
Q3
$910K Hold
6,667
0.01% 917
2017
Q2
$1.17M Hold
6,667
0.01% 880
2017
Q1
$800K Hold
6,667
﹤0.01% 941
2016
Q4
$650K Sell
6,667
-166
-2% -$15.2K ﹤0.01% 974
2016
Q3
$642K Hold
6,833
﹤0.01% 984
2016
Q2
$736K Hold
6,833
﹤0.01% 972
2016
Q1
$820K Hold
6,833
﹤0.01% 931
2015
Q4
$814K Hold
6,833
﹤0.01% 931
2015
Q3
$1.16M Hold
6,833
0.01% 827
2015
Q2
$1.32M Hold
6,833
0.01% 833
2015
Q1
$1.01M Hold
6,833
0.01% 871
2014
Q4
$1.07M Sell
6,833
-167
-2% -$24.1K 0.01% 877
2014
Q3
$1M Hold
7,000
0.01% 886
2014
Q2
$914K Hold
7,000
﹤0.01% 890
2014
Q1
$857K Hold
7,000
﹤0.01% 883
2013
Q4
$743K Hold
7,000
﹤0.01% 886
2013
Q3
$785K Hold
7,000
﹤0.01% 875
2013
Q2
$790K Buy
+7,000
New +$856K ﹤0.01% 860

Other funds holding SRGA

Gabelli Funds's SRGA Position: Q2 2022 in Review

Gabelli Funds sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 1,300 shares — an estimated $12K sold.

Gabelli Funds first reported a position in SRGA in Q2 2013 and held it in 36 quarters. The position peaked at $1.32M in Q2 2015. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

  • Gabelli Funds reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Gabelli Funds sold 1,300 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $12K.
  • Gabelli Funds first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 36 quarters.
  • Gabelli Funds's Surgalign Holdings, Inc. Common Stock position peaked at $1.32M in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on Gabelli Funds's 13F filing for Q2 2022, filed 12 Aug 2022.